<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="23359">Colchicine</z:chebi> is one of the oldest drugs known to us </plain></SENT>
<SENT sid="1" pm="."><plain>During the last few years, it has been increasingly applied in the treatment of systemic <z:e sem="disease" ids="C0037274" disease_type="Disease or Syndrome" abbrv="">dermatoses</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Particularly in <z:e sem="disease" ids="C0037274" disease_type="Disease or Syndrome" abbrv="">dermatoses</z:e> mediated by neutrophils, <z:chebi fb="0" ids="23359">colchicine</z:chebi> has settled among other therapies </plain></SENT>
<SENT sid="3" pm="."><plain>With regard to <z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et's disease, it has even become the treatment of choice </plain></SENT>
<SENT sid="4" pm="."><plain>The present review deals with further <z:e sem="disease" ids="C0037274" disease_type="Disease or Syndrome" abbrv="">dermatological disorders</z:e> sensitive to <z:chebi fb="0" ids="23359">colchicine</z:chebi>; in addition, we mention those <z:e sem="disease" ids="C0037274" disease_type="Disease or Syndrome" abbrv="">dermatoses</z:e> which do not show any therapeutic response to <z:chebi fb="0" ids="23359">colchicine</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>The treatment with <z:chebi fb="0" ids="23359">colchicine</z:chebi> requires profound knowledge of the pharmacokinetics and mode of action regarding this substance, as well as the possible side effects </plain></SENT>
<SENT sid="6" pm="."><plain>This knowledge allows safe and responsible treatment with <z:chebi fb="0" ids="23359">colchicine</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>It has to be considered, however, that in the Federal Republic of Germany <z:chebi fb="0" ids="23359">colchicine</z:chebi> has not been registered for dermatological indications yet </plain></SENT>
</text></document>